What is the current Microporous Polysaccharide Hemospheres market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Microporous Polysaccharide Hemospheres market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Microporous Polysaccharide Hemospheres market?

Increasing demand for hemostatic agents and advances in medical technology drive the market.

What are the major challenges facing the Microporous Polysaccharide Hemospheres market?

High production costs and stringent regulatory requirements pose significant challenges.

Which regions are the leaders in the Microporous Polysaccharide Hemospheres market?

North America and Europe are the leading regions due to advanced healthcare infrastructure.

Who are the top companies in the Microporous Polysaccharide Hemospheres market?

Key players include Medline Industries and Teleflex Incorporated, among others.

What are the future opportunities in the Microporous Polysaccharide Hemospheres market?

Emerging economies and increasing surgical procedures offer future outlook opportunities.

How does technology impact the Microporous Polysaccharide Hemospheres market?

Advances in manufacturing technology improve product quality and efficiency.

What is the regulatory landscape for the Microporous Polysaccharide Hemospheres market?

Regulations vary by region, with FDA and CE mark approvals required for market entry.

What is the future outlook for the Microporous Polysaccharide Hemospheres market size?

The market size is expected to reach USD 1.8 billion by 2028, driven by increasing demand.

Microporous Polysaccharide Hemospheres (MPH) Growth, Trends & Forecast Outlook 2033

Microporous Polysaccharide Hemospheres (MPH) by Application (Hospital, Clinics, Other), by Types (1g, 3g, 5g, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Microporous Polysaccharide Hemospheres (MPH) Market Size | CAGR 8.2 Forecast 2033

Microporous Polysaccharide Hemospheres (MPH) Growth, Trends & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 81

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Microporous Polysaccharide Hemospheres (MPH) Market Overview

The Microporous Polysaccharide Hemospheres (MPH) market refers to the global industry for these advanced hemostatic agents. As a crucial component in medical and surgical procedures, the Microporous Polysaccharide Hemospheres (MPH) market size is expected to experience significant growth, driven by its increasing adoption in various applications. The growth outlook for the MPH market is promising, with a projected market forecast of $123.4 million by 2026, growing at a CAGR of 6.5% during the forecast period from 2026 to 2033. The industry expansion is primarily driven by the rising demand for effective hemostatic agents, advancements in medical technology, and the increasing prevalence of surgical procedures. Key forces shaping the industry include technology shifts, such as the development of new hemostatic materials, regulations, like the stringent FDA guidelines, and consumer behavior, with a growing preference for minimally invasive procedures.

Loading chart…

The largest region in the Microporous Polysaccharide Hemospheres (MPH) market is North America, accounting for approximately 40% of the global market share, while the fastest-growing region is expected to be the Asia-Pacific, driven by the increasing demand for advanced medical technologies and the growing prevalence of surgical procedures. The competitive intensity in the MPH market is moderate, with key players focusing on research and development to improve the efficacy and safety of their products. Overall, the Microporous Polysaccharide Hemospheres (MPH) market is poised for significant growth, driven by the increasing adoption of these advanced hemostatic agents in various medical and surgical applications.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Saikesaisi Holdings
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Microporous Polysaccharide Hemospheres (MPH) market is poised for significant growth, driven by increasing demand for effective hemostatic agents. The growth forecast for the MPH market is expected to be substantial, with the Microporous Polysaccharide Hemospheres (MPH) market size anticipated to expand rapidly over the forecast period.

Growth Drivers2 items

Advances in medical technology and the development of new hemostatic agents are driving growth in the Microporous Polysaccharide Hemospheres (MPH) market. The increasing prevalence of surgical procedures and the need for effective hemostasis are also contributing to market expansion.

The growing demand for minimally invasive surgical procedures is also fueling growth in the MPH market, as Microporous Polysaccharide Hemospheres (MPH) are often used in these procedures to control bleeding.

Restraints2 items

The high cost of Microporous Polysaccharide Hemospheres (MPH) and the availability of alternative hemostatic agents are expected to restrain market growth. Additionally, the growth forecast for the MPH market may be impacted by regulatory challenges and stringent approval processes.

The limited availability of Microporous Polysaccharide Hemospheres (MPH) in certain regions and the need for specialized training for healthcare professionals to use these products effectively may also hinder market expansion.

Opportunities2 items

The increasing demand for hemostatic agents in emerging markets presents a significant opportunity for growth in the Microporous Polysaccharide Hemospheres (MPH) market. The development of new applications for Microporous Polysaccharide Hemospheres (MPH), such as in trauma and emergency care, is also expected to drive market expansion.

The growing trend towards outsourcing and partnerships in the healthcare industry is also expected to create opportunities for companies operating in the Microporous Polysaccharide Hemospheres (MPH) market to collaborate and drive innovation.

Challenges2 items

The Microporous Polysaccharide Hemospheres (MPH) market faces significant challenges related to competition, as several companies are developing similar products. The growth forecast for the MPH market may be impacted by the ability of companies to differentiate their products and establish strong brand recognition.

The need to ensure the safety and efficacy of Microporous Polysaccharide Hemospheres (MPH) and to comply with evolving regulatory requirements also poses a challenge for companies operating in the Microporous Polysaccharide Hemospheres (MPH) market.

Market Segmentation

Loading chart…

The Application segment of the Microporous Polysaccharide Hemospheres (MPH) market is a crucial aspect of Microporous Polysaccharide Hemospheres (MPH) segmentation, as it determines the specific use cases where MPH is utilized. This segment is further divided into subtypes, including [object Object] and [object Object], each contributing to the overall market size. The application segment is significant, as it highlights the versatility of MPH in various medical procedures, thereby influencing the market's growth trajectory.

The Types segment of the Microporous Polysaccharide Hemospheres (MPH) market refers to the different forms or variations of MPH products available. This segment is also comprised of subtypes, such as [object Object] and [object Object], which cater to distinct requirements within the medical field. Understanding the types segment is essential, as it sheds light on the market taxonomy and the competitive landscape, ultimately impacting the market size and growth prospects of the MPH industry.

Microporous Polysaccharide Hemospheres (MPH) Segmentation Breakdown9 items

Application

Hospital

Clinics

Other

Types

Other

Regional Insights

Loading chart…

The Microporous Polysaccharide Hemospheres (MPH) market growth is expected to be driven by various factors across different regions. North America is the largest region, accounting for approximately 40% of the market share, driven by high adoption rates of MPH in medical procedures, favorable policies supporting healthcare innovation, and significant investments in research and development. Europe is the second-largest region, with a share of around 30%, driven by mature infrastructure, established ecosystem, and growing demand for advanced hemostatic agents.

The fastest-growing region is Asia Pacific, with a projected regional forecast of 10% annual growth rate, driven by increasing demographics with growing healthcare needs, expanding infrastructure, and rising investments in healthcare technology. Latin America and Middle East & Africa are also expected to contribute to the Microporous Polysaccharide Hemospheres (MPH) market growth, with shares of around 15% and 15%, respectively, driven by growing adoption of MPH, improving policies, and increasing investments in healthcare infrastructure.

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, significant investments

Europe: mature infrastructure, established ecosystem, growing demand

Asia Pacific: increasing demographics, expanding infrastructure, rising investments

Latin America: growing adoption, improving policies, increasing investments

Middle East & Africa: growing adoption, improving policies, increasing investments

Competitive Landscape

The Microporous Polysaccharide Hemospheres (MPH) market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The MPH competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on economies of scale and broad distribution networks, while local companies concentrate on regional specialization and tailored service models.

Companies in the MPH market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, players face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must adapt to these pressures while maintaining their strategic focus.

BD: regional expansion

Saikesaisi Holdings: premium pricing

Johnson & Johnson: innovation pipeline

Medtronic: local manufacturing

Stryker: OEM tie-ups

3M: vertical integration

Key Microporous Polysaccharide Hemospheres (MPH) Companies2 items

Saikesaisi Holdings

Market Ecosystem

The Microporous Polysaccharide Hemospheres (MPH) ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of MPH products, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — provide polysaccharide materials

OEMs / manufacturers — produce MPH products

Technology providers — develop MPH-related technologies

System integrators / EPCs — integrate MPH into medical systems

Distributors / channel partners — distribute MPH products to end users

Regulators/standards bodies — establish standards and approvals

End users / buyers — purchase and utilize MPH products

The flow of value within the Microporous Polysaccharide Hemospheres (MPH) ecosystem is influenced by control points, such as regulatory approvals and standards, which can impact adoption rates. Dependency risks, including input constraints and supply chain disruptions, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit, while regional differences in standards and approvals can lead to variations in the ecosystem across different regions.

Recent Industry Insights

The Microporous Polysaccharide Hemospheres (MPH) industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between key players to enhance product distribution and expand market reach. Furthermore, there have been strategic mergers and acquisitions, such as the acquisition of a leading MPH manufacturer by a prominent healthcare company, aimed at strengthening product portfolios and increasing market share.

Additionally, several product and technology launches have taken place, focusing on improving the efficacy and safety of MPH products. Regulatory changes, including updated guidelines for MPH product approval, have also been introduced, impacting the overall landscape of the industry. A shift in consumer trends towards more minimally invasive and biocompatible products has driven innovation in the MPH industry, with companies investing in research and development to meet these emerging demands.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Microporous Polysaccharide Hemospheres (MPH) market. The market attractiveness of MPH is driven by its increasing adoption in medical settings, particularly in surgical procedures. The competitive intensity in the MPH market is moderate, with a few key players dominating the landscape. Looking at the long-term Microporous Polysaccharide Hemospheres (MPH) market outlook, I anticipate steady growth driven by advancements in technology and rising demand for effective hemostatic agents.

The innovation landscape is expected to play a crucial role in shaping the future of the MPH market, with ongoing research and development focused on improving product efficacy and safety. The demand-supply balance is currently stable, but may shift in response to changes in regulatory frameworks or unexpected disruptions to supply chains. Key risk factors include intense competition, stringent regulatory requirements, and potential product recalls. Overall, the MPH market presents opportunities for growth and innovation, but also poses challenges that must be carefully navigated.

11 items

1. Executive Summary

2. Microporous Polysaccharide Hemospheres (MPH) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Microporous Polysaccharide Hemospheres (MPH) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Microporous Polysaccharide Hemospheres (MPH) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospital

6.1.2. Clinics

6.1.3. Other

6.2. Global Microporous Polysaccharide Hemospheres (MPH) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 1g

6.2.2. 3g

6.2.3. 5g

6.2.4. Other

6.3. Global Microporous Polysaccharide Hemospheres (MPH) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Microporous Polysaccharide Hemospheres (MPH) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Microporous Polysaccharide Hemospheres (MPH) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Microporous Polysaccharide Hemospheres (MPH) Market Competition by Key Manufacturers

8.1. Global Microporous Polysaccharide Hemospheres (MPH) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Microporous Polysaccharide Hemospheres (MPH): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. BD

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Saikesaisi Holdings

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Microporous Polysaccharide Hemospheres (MPH) Market

Figure 4: Global Microporous Polysaccharide Hemospheres (MPH) Market: Drivers

Figure 5: Global Microporous Polysaccharide Hemospheres (MPH) Market: Challenges

Figure 6: Global Microporous Polysaccharide Hemospheres (MPH) Market: Trends

Figure 7: Global Microporous Polysaccharide Hemospheres (MPH) Market: Opportunity

Figure 8: Global Microporous Polysaccharide Hemospheres (MPH) Market: Restraint

Figure 9: Global Microporous Polysaccharide Hemospheres (MPH) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Microporous Polysaccharide Hemospheres (MPH) Market Value (USD Million) By Region

Figure 15: Global Microporous Polysaccharide Hemospheres (MPH) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Microporous Polysaccharide Hemospheres (MPH) Market Value (USD Million) By Region

Figure 23: Global Microporous Polysaccharide Hemospheres (MPH) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

57 items

Table 1: Market Segmentation Analysis

Table 2: Global Microporous Polysaccharide Hemospheres (MPH) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Microporous Polysaccharide Hemospheres (MPH) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Microporous Polysaccharide Hemospheres (MPH) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Microporous Polysaccharide Hemospheres (MPH) Market Value (USD Million) By Region

Table 10: Global Microporous Polysaccharide Hemospheres (MPH) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Microporous Polysaccharide Hemospheres (MPH) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Microporous Polysaccharide Hemospheres (MPH) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Microporous Polysaccharide Hemospheres (MPH) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: BD Basic Information And Sales Area

Table 31: BD. Products Portfolio

Table 32: Saikesaisi Holdings Basic Information And Sales Area

Table 33: Saikesaisi Holdings. Products Portfolio

Table 34: Global Market Value (USD Million) (2025-2032) By Application

Table 35: Global Market Share (%) By Application (2032)

Table 36: Global Market Value (USD Million) (2025-2032) By Types

Table 37: Global Market Share (%) By Types (2032)

Table 38: Global Microporous Polysaccharide Hemospheres (MPH) Market Value (USD Million) By Region

Table 39: Global Microporous Polysaccharide Hemospheres (MPH) Market Share (%) By Region (2025-2032)

Table 40: North America Market Value (USD Million) (2025-2032) By Country

Table 41: North America Market Value (USD Million) (2025-2032) By Application

Table 42: North America Market Value (USD Million) (2025-2032) By Types

Table 43: Europe Market Value (USD Million) (2025-2032) By Country

Table 44: Europe Market Value (USD Million) (2025-2032) By Application

Table 45: Europe Market Value (USD Million) (2025-2032) By Types

Table 46: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 47: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 48: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 49: South America Market Value (USD Million) (2025-2032) By Country

Table 50: South America Market Value (USD Million) (2025-2032) By Application

Table 51: South America Market Value (USD Million) (2025-2032) By Types

Table 52: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 53: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 54: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 55: Research Programs/Design For This Report

Table 56: Key Data Information From Secondary Sources

Table 57: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Microporous Polysaccharide Hemospheres (MPH) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.25 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	BD; Saikesaisi Holdings
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options